Table 3.
Concentration of lenalidomide (nM) (percentage of control, mean±S.D.) | |||||
---|---|---|---|---|---|
10 | 30 | 100 | 300 | 1000 | |
Incubation time (h) | |||||
6 | 91 ±14 | 78±13 | 67±7.8* | 65±4.5** | 46 ±14* |
24 | 69±11* | 54±17* | 35 ±4.0** | 33±1.5** | 20±4.5** |
48 | 73 ±12 | 57±2.5** | 48±3.2** | 36±4.6** | 36 ±7.6** |
Each value is the mean +S.D. of the results from studies of two adults of ages 21–45 and two adults of ages N65 years. Production of TNF-α evoked by 100 ng/ml of LPS in the absence of lenalidomide (100% control) ranged from 4439 to 6039 pg/ml, 1843 to 2038 pg/ml, and 222 to 308 pg/ml after 6, 24 and 48 h of incubation. The significance of decreases in TNF-α generation induced by lenalidomide relative to the control (100%) value were calculated by a two-sample t test;
=pb0.05,
=pb0.01 and
=pb0.001.